@dansfera: Is the FSP model losing its grip on the clinical research world? 📉 It’s easy to look at the current landscape and assume the Functional Service Provider approach is on the decline, but the reality is far more nuanced. Cycles in this industry are inevitable, and what looks like a downturn might just be a shift in strategy. CROs actually stand to make more profit with full-service models, raising the question: Are sponsors steering the ship back toward full-service, or is the biotech funding resurgence fueling a different path? The data suggests biotech outsourcing is outpacing pharma, and that shift is changing everything. Whether FSP is down for the count or just catching its breath remains to be seen. #clinicalresearch #CRO #biotech #pharmaceuticals #FSPmodel